Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1995
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2187938A1 Use of g-csf to reduce acute rejection
10/26/1995CA2187770A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2186252A1 Substituted pyridine leukotriene b4 antagonists
10/25/1995EP0678508A1 Indoles as inhibitors of HIV reverse transcriptase
10/25/1995EP0678298A2 Use of 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid as immopotentiatory agent
10/25/1995EP0678297A1 Iontophoretic transdermal delivery of deoxyspergualin compounds
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678099A1 New peptides
10/25/1995EP0678034A1 Inducing cytotoxic t lymphocyte responses
10/25/1995CN1110563A Injection containing ginseng and astragalus root components
10/24/1995US5461154 HIV protease inhibitors
10/24/1995US5461059 Derivatives of terbutylphenyl-1-amino-4-hydroxybutane their preparation processes and the pharmaceutical compositions containing them
10/24/1995US5461058 Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
10/24/1995US5461054 Anthracene-spiro-pyrrolindines
10/24/1995US5461050 Antiallergens
10/24/1995US5461033 Administering transforming growth factor-beta containing acid casein fraction isolated from bovine milk to treat crohn's disease
10/24/1995CA1337408C Soluble phosphorylated glucan
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027786A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995WO1995027733A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027506A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995WO1995027502A1 Method of treating auto-immune diseases using type one interferons
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027487A1 Method of treating allergic rhinitis
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187550A1 Method of treating auto-immune diseases using type one interferons
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2187336A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995CA2187299A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995CA2164729A1 Catalase-based anti-helicobacter pylori immunising composition
10/18/1995EP0677532A1 Use of Il-1-antagonists as medicaments for treating diseases with increased Interleukin-6 serum levels
10/18/1995EP0677524A1 Thieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives as PAF antagonists
10/18/1995EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677051A1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676958A1 Method for inhibiting intracellular viral replication
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1030075C Process for preparing 3-cycloalkyl-propanamides, their tautomer forms and their salts
10/17/1995US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459150 Treatment of allergies and inflammatory diseases
10/17/1995US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds
10/17/1995US5459128 Restenosis inhibitors
10/17/1995CA2048894C Method of treating mast cell disease
10/12/1995WO1995027202A1 Screening method using the rzr receptor family
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995026979A1 Cytotoxic t-cell lymphocyte ('ctl') activity regulation by class i mhc peptides
10/12/1995WO1995026958A1 Pyrimidinyl derivatives as interleukin inhibitors
10/12/1995WO1995026738A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995WO1995026727A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995WO1995026718A1 Compositions and methods for delivery of genetic material
10/12/1995WO1995024923A3 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
10/12/1995DE4411660A1 Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung The use of xanthine derivatives for reducing the pathological hyperreactivity eosinophilic granulocytes, new xanthine compounds and processes for their preparation
10/12/1995CA2187193A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2187081A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995CA2186913A1 Compositions and methods for delivery of genetic material
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186758A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/11/1995EP0676472A1 Human manganese superoxide dismutase (hMn-SOD)
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676470A1 Stem cell factor
10/11/1995EP0676467A2 European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0676207A2 Anticomplementary agent prepared from fucans of brown seaweed
10/11/1995EP0675889A1 Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives
10/11/1995EP0675887A1 Antiallergic triazolobenzazepine derivatives
10/11/1995EP0675886A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
10/11/1995EP0675881A1 Use of benzotriazines as pla 2? inhibitors, and new benzotriazines.
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675734A1 ALLERGEN-SPECIFIC IgA MONOCLONAL ANTIBODIES AND RELATED PRODUCTS FOR ALLERGY TREATMENT
10/11/1995EP0675732A1 Use of relaxin as therapeutic or preventing agent
10/11/1995EP0675721A1 Pharmaceutical compositions comprising contignasterol compounds
10/11/1995EP0675719A1 Novel combination of benzoquinazoline antifolates and protecting agents
10/11/1995EP0675718A1 Substituted pyridyl compounds useful as leukotriene antagonists
10/11/1995EP0675715A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
10/11/1995EP0538330B1 Beta-alethine use in cell culture and therapy
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995CN1109884A Methods of inhibiting myeloperoxidase activity
10/11/1995CN1109870A N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application of same
10/11/1995CN1109748A Rapamycin formulation for IV injection
10/11/1995CN1029971C Process for preparating antiviral tetrahydroimidazo (1,4) benzodiazepines
10/11/1995CN1029967C New xanthine derivatives
10/11/1995CN1029964C Novel N-(4-piperidinyl) bicyclic condensed 2-imiolazolamine derivatives
1 ... 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 ... 1172